Literature DB >> 8839159

Role of IL12 in induction of cell-mediated immunity to Toxoplasma gondii.

T Scharton-Kersten1, E Y Denkers, R Gazzinelli, A Sher.   

Abstract

Mesh：

Substances：

Year:  1995        PMID： 8839159     DOI： 10.1016/0923-2494(96)83029-x

Source DB:  PubMed          Journal:  Res Immunol        ISSN： 0923-2494


× No keyword cloud information.
  13 in total

1.  Lack of IL-15 results in the suboptimal priming of CD4+ T cell response against an intracellular parasite.

Authors:  Crescent L Combe; Magali M Moretto; Joseph D Schwartzman; Jason P Gigley; David J Bzik; Imtiaz A Khan
Journal:  Proc Natl Acad Sci U S A       Date:  2006-04-13       Impact factor: 11.205

2.  Protective role for interleukin-5 during chronic Toxoplasma gondii infection.

Authors:  Y Zhang; E Y Denkers
Journal:  Infect Immun       Date:  1999-09       Impact factor: 3.441

3.  Localized multigene expression patterns support an evolving Th1/Th2-like paradigm in response to infections with Toxoplasma gondii and Ascaris suum.

Authors:  Harry D Dawson; Ethiopia Beshah; Sandra Nishi; Gloria Solano-Aguilar; Motoko Morimoto; Aiping Zhao; Kathleen B Madden; Tonya K Ledbetter; J P Dubey; Terez Shea-Donohue; Joan K Lunney; Joseph F Urban
Journal:  Infect Immun       Date:  2005-02       Impact factor: 3.441

4.  Evaluation of a cyclic GMP-dependent protein kinase inhibitor in treatment of murine toxoplasmosis: gamma interferon is required for efficacy.

Authors:  Bakela Nare; John J Allocco; Paul A Liberator; Robert G K Donald
Journal:  Antimicrob Agents Chemother       Date:  2002-02       Impact factor: 5.191

5.  NF-kappaB1 contributes to T cell-mediated control of Toxoplasma gondii in the CNS.

Authors:  Tajie H Harris; Emma H Wilson; Elia D Tait; Marie Buckley; Sagi Shapira; Jorge Caamano; David Artis; Christopher A Hunter
Journal:  J Neuroimmunol       Date:  2010-02-13       Impact factor: 3.478

Review 6.  Interleukin-12 in infectious diseases.

Authors:  L Romani; P Puccetti; F Bistoni
Journal:  Clin Microbiol Rev       Date:  1997-10       Impact factor: 26.132

7.  Toxoplasma gondii triggers granulocyte-dependent cytokine-mediated lethal shock in D-galactosamine-sensitized mice.

Authors:  A J Marshall; E Y Denkers
Journal:  Infect Immun       Date:  1998-04       Impact factor: 3.441

8.  The unexpected role for the aryl hydrocarbon receptor on susceptibility to experimental toxoplasmosis.

Authors:  Yuriko Sanchez; Juan de Dios Rosado; Libia Vega; Guillermo Elizondo; Elizabeth Estrada-Muñiz; Rafael Saavedra; Imelda Juárez; Miriam Rodríguez-Sosa
Journal:  J Biomed Biotechnol       Date:  2010-01-11

9.  Improvement of a dendritic cell-based therapeutic cancer vaccine with components of Toxoplasma gondii.

Authors:  Masoumeh Motamedi; Samaneh Arab; Seied Mohammad Moazzeni; Masoomeh Khamis Abadi; Jamshid Hadjati
Journal:  Clin Vaccine Immunol       Date:  2009-08-05

10.  Macrophage migration inhibitory factor (MIF) is critical for the host resistance against Toxoplasma gondii.

Authors:  Marcos Flores; Rafael Saavedra; Rocio Bautista; Rubi Viedma; Eda P Tenorio; Lin Leng; Yuriko Sánchez; Imelda Juárez; Anjali A Satoskar; Asha S Shenoy; Luis I Terrazas; Richard Bucala; Joseph Barbi; Abhay R Satoskar; Miriam Rodriguez-Sosa
Journal:  FASEB J       Date:  2008-07-07       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.